查看購物車
  • Simplified Chinese
  • English
封面
市場調查報告書
商品編碼
1459783

荷爾蒙避孕市場（方法：口服避孕藥、經皮貼片、注射避孕藥、子宮內避孕藥和陰道環）- 2023-2031 年全球產業分析、規模、佔有率、成長、趨勢和預測

Hormonal Contraceptive Market (Method: Oral Contraceptives, Transdermal Patches, Injectable Contraceptives, Intrauterine Contraceptives, and Vaginal Rings) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2023-2031
出版日期: | 出版商: Transparency Market Research | 英文 161 Pages | 商品交期: 2-10個工作天內

價格

荷爾蒙避孕市場 - 報告範圍

TMR 關於全球荷爾蒙避孕藥市場的報告研究了過去以及當前的成長趨勢和機會，以獲得 2023 年至 2031 年預測期內市場指標的寶貴見解。該報告提供了全球荷爾蒙避孕藥市場的收入2017-2031年期間，考慮2023年為基準年，2031年為預測年。報告中也提供了2023年至2031年全球荷爾蒙避孕藥市場的年複合成長率（CAGR %）。

該報告是經過廣泛研究後編寫的。初級研究涉及大部分研究工作，其中分析師對關鍵意見領袖、行業領導者和輿論製造者進行了採訪。二次研究涉及參考主要參與者的產品文獻、年度報告、新聞稿和相關文件，以了解荷爾蒙避孕藥市場。

市場概況
2022年市場價​​值 218 億美元
2031 年市場價值 338 億美元
CAGR 5%

該報告深入研究了全球荷爾蒙避孕藥市場的競爭格局。全球荷爾蒙避孕藥市場的主要參與者已被確定，並且每一位參與者都已根據各種屬性進行了分析。公司概況、財務狀況、最新發展和 SWOT 是本報告中介紹的全球荷爾蒙避孕藥市場參與者的屬性。

表內容

第1章：前言

第 2 章：假設與研究方法

第 3 章：執行摘要：荷爾蒙避孕市場

第 4 章：市場概覽

  • 介紹
  • 概述
  • 市場動態
  • 2017-2031年荷爾蒙避孕藥市場分析與預測

第 5 章：關鍵見解

  • 管道分析
  • 關鍵技術/品牌分析
  • 主要併購
  • COVID-19 大流行對該行業的影響

第 6 章：荷爾蒙避孕藥市場分析與預測：依方法

  • 簡介與定義
  • 主要發現/進展
  • 市場價值預測：依方法分類，2017-2031
    • 口服避孕藥
    • 經皮貼劑
    • 注射避孕藥
    • 子宮內避孕藥
    • 陰道環
  • 市場吸引力分析：依方法

第 7 章：荷爾蒙避孕藥市場分析與預測：依荷爾蒙分類

  • 簡介與定義
  • 主要發現/進展
  • 市場價值預測：依激素分類，2017-2031
    • 僅孕激素
    • 組合荷爾蒙
  • 市場吸引力分析：按激素

第 8 章：荷爾蒙避孕藥市場分析與預測：按配銷通路

  • 簡介與定義
  • 主要發現/進展
  • 市場價值預測：按配銷通路，2017-2031
    • 藥局
    • 婦科/生育診所
    • 電子商務
    • 其他
  • 市場吸引力分析：按激素

第 9 章：荷爾蒙避孕藥市場分析與預測：按地區

  • 主要發現
  • 市場價值預測：按地區，2017-2031
    • 北美洲
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東和非洲
  • 市場吸引力分析：按地區

第 10 章：北美荷爾蒙避孕藥市場分析與預測

第 11 章：歐洲荷爾蒙避孕市場分析與預測

第 12 章：亞太地區荷爾蒙避孕市場分析與預測

第 13 章：拉丁美洲荷爾蒙避孕市場分析與預測

第 14 章：中東與非洲荷爾蒙避孕市場分析與預測

第 15 章：競爭格局

  • 市場參與者 - 競爭矩陣（按級別和規模公司）
  • 市佔率分析：依公司分類（2022 年）
  • 公司簡介
    • AbbVie, Inc.
    • Afaxys, Inc.
    • Bayer AG
    • Agile Therapeutics
    • Merck & Co., Inc.
    • Piramal Enterprises Ltd.
    • Pfizer Inc.
    • HLL Lifecare Limited
Product Code: TMRGL49380

Hormonal Contraceptive Market - Scope of Report

TMR's report on the global hormonal contraceptives market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2031. The report provides revenue of the global hormonal contraceptives market for the period 2017-2031, considering 2023 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global hormonal contraceptives market from 2023 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the hormonal contraceptives market.

Market Snapshot
Market Value in 2022US$ 21.8 Bn
Market Value in 2031US$ 33.8 Bn
CAGR5%

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global hormonal contraceptives market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global hormonal contraceptives market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global hormonal contraceptives market.

The report delves into the competitive landscape of the global hormonal contraceptives market. Key players operating in the global hormonal contraceptives market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global hormonal contraceptives market profiled in this report.

Key Questions Answered in Global hormonal contraceptives Market Report:

  • What is the sales/revenue generated by hormonal contraceptives across all regions during the forecast period?
  • What are the opportunities in the global hormonal contraceptives market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2031?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?

Hormonal Contraceptive Market - Research Objectives and Research Approach

The comprehensive report on the global hormonal contraceptives market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global hormonal contraceptives market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global hormonal contraceptives market.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Hormonal Contraceptive Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Technology Definition
    • 4.1.2. Industry Evolution/Developments
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Hormonal Contraceptive Market Analysis and Forecast, 2017-2031

5. Key Insights

  • 5.1. Pipeline Analysis
  • 5.2. Key Technology/Brand Analysis
  • 5.3. Key Mergers & Acquisitions
  • 5.4. COVID-19 Pandemic Impact on Industry

6. Hormonal Contraceptive Market Analysis and Forecast, by Method

  • 6.1. Introduction & Definition
  • 6.2. Key Findings/Developments
  • 6.3. Market Value Forecast, by Method, 2017-2031
    • 6.3.1. Oral Contraceptives
    • 6.3.2. Transdermal Patches
    • 6.3.3. Injectable Contraceptives
    • 6.3.4. Intrauterine Contraceptives
    • 6.3.5. Vaginal Rings
  • 6.4. Market Attractiveness Analysis, by Method

7. Hormonal Contraceptive Market Analysis and Forecast, by Hormones

  • 7.1. Introduction & Definition
  • 7.2. Key Findings/Developments
  • 7.3. Market Value Forecast, by Hormones, 2017-2031
    • 7.3.1. Progestin Only
    • 7.3.2. Combined Hormones
  • 7.4. Market Attractiveness Analysis, by Hormones

8. Hormonal Contraceptive Market Analysis and Forecast, by Distribution Channel

  • 8.1. Introduction & Definition
  • 8.2. Key Findings/Developments
  • 8.3. Market Value Forecast, by Distribution Channel, 2017-2031
    • 8.3.1. Drug Stores
    • 8.3.2. Gynecology/Fertility Clinics
    • 8.3.3. E-commerce
    • 8.3.4. Others
  • 8.4. Market Attractiveness Analysis, by Hormones

9. Hormonal Contraceptive Market Analysis and Forecast, by Region

  • 9.1. Key Findings
  • 9.2. Market Value Forecast, by Region, 2017-2031
    • 9.2.1. North America
    • 9.2.2. Europe
    • 9.2.3. Asia Pacific
    • 9.2.4. Latin America
    • 9.2.5. Middle East & Africa
  • 9.3. Market Attractiveness Analysis, by Region

10. North America Hormonal Contraceptive Market Analysis and Forecast

  • 10.1. Introduction
  • 10.2. Key Findings
  • 10.3. Market Value Forecast, by Method, 2017-2031
    • 10.3.1. Oral Contraceptives
    • 10.3.2. Transdermal Patches
    • 10.3.3. Injectable Contraceptives
    • 10.3.4. Intrauterine Contraceptives
    • 10.3.5. Vaginal Rings
  • 10.4. Market Value Forecast, by Hormones, 2017-2031
    • 10.4.1. Progestin Only
    • 10.4.2. Combined Hormones
  • 10.5. Market Value Forecast, by Distribution Channel, 2017-2031
    • 10.5.1. Drug Stores
    • 10.5.2. Gynecology/Fertility Clinics
    • 10.5.3. E-commerce
    • 10.5.4. Others
  • 10.6. Market Value Forecast, by Country, 2017-2031
    • 10.6.1. U.S.
    • 10.6.2. Canada
  • 10.7. Market Attractiveness Analysis
    • 10.7.1. By Method
    • 10.7.2. By Hormones
    • 10.7.3. By Distribution Channel
    • 10.7.4. By Country

11. Europe Hormonal Contraceptive Market Analysis and Forecast

  • 11.1. Introduction
  • 11.2. Key Findings
  • 11.3. Market Value Forecast, by Method, 2017-2031
    • 11.3.1. Oral Contraceptives
    • 11.3.2. Transdermal Patches
    • 11.3.3. Injectable Contraceptives
    • 11.3.4. Intrauterine Contraceptives
    • 11.3.5. Vaginal Rings
  • 11.4. Market Value Forecast, by Hormones, 2017-2031
    • 11.4.1. Progestin Only
    • 11.4.2. Combined Hormones
  • 11.5. Market Value Forecast, by Distribution Channel, 2017-2031
    • 11.5.1. Drug Stores
    • 11.5.2. Gynecology/Fertility Clinics
    • 11.5.3. E-commerce
    • 11.5.4. Others
  • 11.6. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 11.6.1. Germany
    • 11.6.2. U.K.
    • 11.6.3. France
    • 11.6.4. Italy
    • 11.6.5. Spain
    • 11.6.6. Rest of Europe
  • 11.7. Market Attractiveness Analysis
    • 11.7.1. By Method
    • 11.7.2. By Hormones
    • 11.7.3. By Distribution Channel
    • 11.7.4. By Country/Sub-region

12. Asia Pacific Hormonal Contraceptive Market Analysis and Forecast

  • 12.1. Introduction
  • 12.2. Key Findings
  • 12.3. Market Value Forecast, by Method, 2017-2031
    • 12.3.1. Oral Contraceptives
    • 12.3.2. Transdermal Patches
    • 12.3.3. Injectable Contraceptives
    • 12.3.4. Intrauterine Contraceptives
    • 12.3.5. Vaginal Rings
  • 12.4. Market Value Forecast, by Hormones, 2017-2031
    • 12.4.1. Progestin Only
    • 12.4.2. Combined Hormones
  • 12.5. Market Value Forecast, by Distribution Channel, 2017-2031
    • 12.5.1. Drug Stores
    • 12.5.2. Gynecology/Fertility Clinics
    • 12.5.3. E-commerce
    • 12.5.4. Others
  • 12.6. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 12.6.1. China
    • 12.6.2. Japan
    • 12.6.3. India
    • 12.6.4. Australia & New Zealand
    • 12.6.5. Rest of Asia Pacific
  • 12.7. Market Attractiveness Analysis
    • 12.7.1. By Method,
    • 12.7.2. By Hormones
    • 12.7.3. By Distribution Channel
    • 12.7.4. By Country/Sub-region

13. Latin America Hormonal Contraceptive Market Analysis and Forecast

  • 13.1. Introduction
  • 13.2. Key Findings
  • 13.3. Market Value Forecast, by Method, 2017-2031
    • 13.3.1. Oral Contraceptives
    • 13.3.2. Transdermal Patches
    • 13.3.3. Injectable Contraceptives
    • 13.3.4. Intrauterine Contraceptives
    • 13.3.5. Vaginal Rings
  • 13.4. Market Value Forecast, by Hormones, 2017-2031
    • 13.4.1. Progestin Only
    • 13.4.2. Combined Hormones
  • 13.5. Market Value Forecast, by Distribution Channel, 2017-2031
    • 13.5.1. Drug Stores
    • 13.5.2. Gynecology/Fertility Clinics
    • 13.5.3. E-commerce
    • 13.5.4. Others
  • 13.6. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 13.6.1. Brazil
    • 13.6.2. Mexico
    • 13.6.3. Rest of Latin America
  • 13.7. Market Attractiveness Analysis
    • 13.7.1. By Method,
    • 13.7.2. By Hormones
    • 13.7.3. By Distribution Channel
    • 13.7.4. By Country/Sub-region

14. Middle East & Africa Hormonal Contraceptive Market Analysis and Forecast

  • 14.1. Introduction
  • 14.2. Key Findings
  • 14.3. Market Value Forecast, by Method, 2017-2031
    • 14.3.1. Oral Contraceptives
    • 14.3.2. Transdermal Patches
    • 14.3.3. Injectable Contraceptives
    • 14.3.4. Intrauterine Contraceptives
    • 14.3.5. Vaginal Rings
  • 14.4. Market Value Forecast, by Hormones, 2017-2031
    • 14.4.1. Progestin Only
    • 14.4.2. Combined Hormones
  • 14.5. Market Value Forecast, by Distribution Channel, 2017-2031
    • 14.5.1. Drug Stores
    • 14.5.2. Gynecology/Fertility Clinics
    • 14.5.3. E-commerce
    • 14.5.4. Others
  • 14.6. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 14.6.1. GCC Countries
    • 14.6.2. South Africa
    • 14.6.3. Rest of Middle East & Africa
  • 14.7. Market Attractiveness Analysis
    • 14.7.1. By Method,
    • 14.7.2. By Hormones
    • 14.7.3. By Distribution Channel
    • 14.7.4. By Country/Sub-region

15. Competition Landscape

  • 15.1. Market Player - Competitive Matrix (by Tier and Size of Companies)
  • 15.2. Market Share Analysis, by Company (2022)
  • 15.3. Company Profiles
    • 15.3.1. AbbVie, Inc.
      • 15.3.1.1. Company Overview
      • 15.3.1.2. Technology, Portfolio
      • 15.3.1.3. SWOT Analysis
      • 15.3.1.4. Financial Overview
      • 15.3.1.5. Strategic Overview
    • 15.3.2. Afaxys, Inc.
      • 15.3.2.1. Company Overview
      • 15.3.2.2. Technology, Portfolio
      • 15.3.2.3. SWOT Analysis
      • 15.3.2.4. Financial Overview
      • 15.3.2.5. Strategic Overview
    • 15.3.3. Bayer AG
      • 15.3.3.1. Company Overview
      • 15.3.3.2. Technology, Portfolio
      • 15.3.3.3. SWOT Analysis
      • 15.3.3.4. Financial Overview
      • 15.3.3.5. Strategic Overview
    • 15.3.4. Agile Therapeutics
      • 15.3.4.1. Company Overview
      • 15.3.4.2. Technology, Portfolio
      • 15.3.4.3. SWOT Analysis
      • 15.3.4.4. Financial Overview
      • 15.3.4.5. Strategic Overview
    • 15.3.5. Merck & Co., Inc.
      • 15.3.5.1. Company Overview
      • 15.3.5.2. Technology, Portfolio
      • 15.3.5.3. SWOT Analysis
      • 15.3.5.4. Financial Overview
      • 15.3.5.5. Strategic Overview
    • 15.3.6. Piramal Enterprises Ltd.
      • 15.3.6.1. Company Overview
      • 15.3.6.2. Technology, Portfolio
      • 15.3.6.3. SWOT Analysis
      • 15.3.6.4. Financial Overview
      • 15.3.6.5. Strategic Overview
    • 15.3.7. Pfizer Inc.
      • 15.3.7.1. Company Overview
      • 15.3.7.2. Technology, Portfolio
      • 15.3.7.3. SWOT Analysis
      • 15.3.7.4. Financial Overview
      • 15.3.7.5. Strategic Overview
    • 15.3.8. HLL Lifecare Limited
      • 15.3.8.1. Company Overview
      • 15.3.8.2. Technology, Portfolio
      • 15.3.8.3. SWOT Analysis
      • 15.3.8.4. Financial Overview
      • 15.3.8.5. Strategic Overview

List of Tables

  • Table 01: Hormonal Contraceptive Market Size (US$ Mn) Forecast, by Method, 2017-2031
  • Table 02: Hormonal Contraceptive Market Size (US$ Mn) Forecast, by Hormones, 2017-2031
  • Table 03: Hormonal Contraceptive Market Size (US$ Mn) Forecast, by Distribution Channel, 2017-2031
  • Table 04: Hormonal Contraceptive Market Size (US$ Mn) Forecast, by Region, 2017-2031
  • Table 05: North America Hormonal Contraceptive Market Size (US$ Mn) Forecast, by Country, 2017-2031
  • Table 06: North America Hormonal Contraceptive Market Size (US$ Mn) Forecast, by Method, 2017-2031
  • Table 07: North America Hormonal Contraceptive Market Size (US$ Mn) Forecast, by Hormones, 2017-2031
  • Table 08: North America Hormonal Contraceptive Market Size (US$ Mn) Forecast, by Distribution Channel, 2017-2031
  • Table 09: Europe Hormonal Contraceptive Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 10: Europe Hormonal Contraceptive Market Size (US$ Mn) Forecast, by Method, 2017-2031
  • Table 11: Europe Hormonal Contraceptive Market Size (US$ Mn) Forecast, by Hormones, 2017-2031
  • Table 12: Europe Hormonal Contraceptive Market Size (US$ Mn) Forecast, by Distribution Channel, 2017-2031
  • Table 13: Asia Pacific Hormonal Contraceptive Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 14: Asia Pacific Hormonal Contraceptive Market Size (US$ Mn) Forecast, by Method, 2017-2031
  • Table 15: Asia Pacific Hormonal Contraceptive Market Size (US$ Mn) Forecast, by Hormones, 2017-2031
  • Table 16: Asia Pacific Hormonal Contraceptive Market Size (US$ Mn) Forecast, by Distribution Channel, 2017-2031
  • Table 17: Latin America Hormonal Contraceptive Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 18: Latin America Hormonal Contraceptive Market Size (US$ Mn) Forecast, by Method, 2017-2031
  • Table 19: Latin America Hormonal Contraceptive Market Size (US$ Mn) Forecast, by Hormones, 2017-2031
  • Table 20: Latin America Hormonal Contraceptive Market Size (US$ Mn) Forecast, by Distribution Channel, 2017-2031
  • Table 21: Middle East & Africa Hormonal Contraceptive Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 22: Middle East & Africa Hormonal Contraceptive Market Size (US$ Mn) Forecast, by Method, 2017-2031
  • Table 23: Middle East & Africa Hormonal Contraceptive Market Size (US$ Mn) Forecast, by Hormones, 2017-2031
  • Table 24: Middle East & Africa Hormonal Contraceptive Market Size (US$ Mn) Forecast, by Distribution Channel, 2017-2031

List of Figures

  • Figure 01: Hormonal Contraceptive Market Size (US$ Mn) and Distribution (%), by Region, 2017-2031
  • Figure 02: Hormonal Contraceptive Market Revenue (US$ Mn), by Method, 2022
  • Figure 03: Hormonal Contraceptive Market Value Share, by Method, 2022
  • Figure 04: Hormonal Contraceptive Market Revenue (US$ Mn), by Hormones, 2022
  • Figure 05: Hormonal Contraceptive Market Value Share, by Hormones, 2022
  • Figure 06: Hormonal Contraceptive Market Revenue (US$ Mn), by Distribution Channel, 2022
  • Figure 07: Hormonal Contraceptive Market Value Share, by Distribution Channel, 2022
  • Figure 08: Hormonal Contraceptive Market Value Share, by Region, 2022
  • Figure 09: Hormonal Contraceptive Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 10: Hormonal Contraceptive Market Value Share Analysis, by Method, 2017-2031
  • Figure 11: Hormonal Contraceptive Market Attractiveness Analysis, by Method, 2017-2031
  • Figure 12: Hormonal Contraceptive Market Value Share Analysis, by Hormones, 2017-2031
  • Figure 13: Hormonal Contraceptive Market Attractiveness Analysis, by Hormones, 2017-2031
  • Figure 14: Hormonal Contraceptive Market Value Share Analysis, by Distribution Channel, 2017-2031
  • Figure 15: Hormonal Contraceptive Market Attractiveness Analysis, by Distribution Channel, 2017-2031
  • Figure 16: Hormonal Contraceptive Market Value Share Analysis, by Region, 2017-2031
  • Figure 17: Hormonal Contraceptive Market Attractiveness Analysis, by Region, 2017-2031
  • Figure 18: North America Hormonal Contraceptive Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017-2031
  • Figure 19: North America Hormonal Contraceptive Market Attractiveness Analysis, by Country, 2017-2031
  • Figure 20: North America Hormonal Contraceptive Market Value Share Analysis, by Country, 2017-2031
  • Figure 21: North America Hormonal Contraceptive Market Value Share Analysis, by Method, 2017-2031
  • Figure 22: North America Hormonal Contraceptive Market Value Share Analysis, by Hormones, 2017-2031
  • Figure 23: North America Hormonal Contraceptive Market Value Share Analysis, by Distribution Channel, 2017-2031
  • Figure 24: North America Hormonal Contraceptive Market Attractiveness Analysis, by Method, 2017-2031
  • Figure 25: North America Hormonal Contraceptive Market Attractiveness Analysis, by Hormones, 2017-2031
  • Figure 26:North America Hormonal Contraceptive Market Attractiveness Analysis, by Distribution Channel, 2017-2031
  • Figure 27: Europe Hormonal Contraceptive Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017-2031
  • Figure 28: Europe Hormonal Contraceptive Market Attractiveness Analysis, by Country/Sub-region, 2017-2031
  • Figure 29: Europe Hormonal Contraceptive Market Value Share Analysis, by Country/Sub-region, 2017-2031
  • Figure 30: Europe Hormonal Contraceptive Market Value Share Analysis, by Method, 2017-2031
  • Figure 31: Europe Hormonal Contraceptive Market Value Share Analysis, by Hormones, 2017-2031
  • Figure 32: Europe Hormonal Contraceptive Market Value Share Analysis, by Distribution Channel, 2017-2031
  • Figure 33: Europe Hormonal Contraceptive Market Attractiveness Analysis, by Method, 2017-2031
  • Figure 34: Europe Hormonal Contraceptive Market Attractiveness Analysis, by Hormones, 2017-2031
  • Figure 35: Europe Hormonal Contraceptive Market Attractiveness Analysis, by Distribution Channel, 2017-2031
  • Figure 36: Asia Pacific Hormonal Contraceptive Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017-2031
  • Figure 37: Asia Pacific Hormonal Contraceptive Market Attractiveness Analysis, by Country/Sub-region, 2017-2031
  • Figure 38: Asia Pacific Hormonal Contraceptive Market Value Share Analysis, by Country/Sub-region, 2017-2031
  • Figure 39: Asia Pacific Hormonal Contraceptive Market Value Share Analysis, by Method, 2017-2031
  • Figure 40: Asia Pacific Hormonal Contraceptive Market Value Share Analysis, by Hormones, 2017-2031
  • Figure 41: Asia Pacific Hormonal Contraceptive Market Value Share Analysis, by Distribution Channel, 2017-2031
  • Figure 42: Asia Pacific Hormonal Contraceptive Market Attractiveness Analysis, by Method, 2017-2031
  • Figure 43: Asia Pacific Hormonal Contraceptive Market Attractiveness Analysis, by Hormones, 2017-2031
  • Figure 44: Asia Pacific Hormonal Contraceptive Market Attractiveness Analysis, by Distribution Channel, 2017-2031
  • Figure 45: Latin America Hormonal Contraceptive Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017-2031
  • Figure 46: Latin America Hormonal Contraceptive Market Attractiveness Analysis, by Country/Sub-region, 2017-2031
  • Figure 47: Latin America Hormonal Contraceptive Market Value Share Analysis, by Country/Sub-region, 2017-2031
  • Figure 48: Latin America Hormonal Contraceptive Market Value Share Analysis, by Method, 2017-2031
  • Figure 49: Latin America Hormonal Contraceptive Market Value Share Analysis, by Hormones, 2017-2031
  • Figure 50: Latin America Hormonal Contraceptive Market Value Share Analysis, by Distribution Channel, 2017-2031
  • Figure 51: Latin America Hormonal Contraceptive Market Attractiveness Analysis, by Method, 2017-2031
  • Figure 52: Latin America Hormonal Contraceptive Market Attractiveness Analysis, by Hormones, 2017-2031
  • Figure 53: Latin America Hormonal Contraceptive Market Attractiveness Analysis, by Distribution Channel, 2017-2031
  • Figure 54: Middle East & Africa Hormonal Contraceptive Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2017-2031
  • Figure 55: Middle East & Africa Hormonal Contraceptive Market Attractiveness Analysis, by Country/Sub-region, 2017-2031
  • Figure 56: Middle East & Africa Hormonal Contraceptive Market Value Share Analysis, by Country/Sub-region, 2017-2031
  • Figure 57: Middle East & Africa Hormonal Contraceptive Market Value Share Analysis, by Method, 2017-2031
  • Figure 58: Middle East & Africa Hormonal Contraceptive Market Value Share Analysis, by Hormones, 2017-2031
  • Figure 59: Middle East & Africa Hormonal Contraceptive Market Value Share Analysis, by Distribution Channel, 2017-2031
  • Figure 60: Middle East & Africa Hormonal Contraceptive Market Attractiveness Analysis, by Method, 2017-2031
  • Figure 61: Middle East & Africa Hormonal Contraceptive Market Attractiveness Analysis, by Hormones, 2017-2031
  • Figure 62: Middle East & Africa Hormonal Contraceptive Market Attractiveness Analysis, by Distribution Channel, 2017-2031